Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World Study Says

(MedPage Today) — Overall survival (OS) in refractory metastatic colorectal cancer (mCRC) improved significantly with the addition of the VEGF inhibitor bevacizumab (Avastin) to chemotherapy, data from a real-world analysis showed.
A propensity…

Source link : https://www.medpagetoday.com/hematologyoncology/coloncancer/120069

Author :

Publish date : 2026-02-26 21:45:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World Study Says

Novel GLP-1 Pill Tops Oral Semaglutide for Diabetes

Related Posts

Novel GLP-1 Pill Tops Oral Semaglutide for Diabetes

Trump Admin to Pause Medicaid Funding to Minnesota Because of Fraud Concerns

Maternity Services ‘Still Failing’ Women and Babies

Very Early ART Initiation in Children With HIV Could Lead to ART-Free Remission

When we interbred with Neanderthals, they were usually the fathers

Did Exercise Really Help Your Hip Osteoarthritis Patients?

Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World Study Says

Novel GLP-1 Pill Tops Oral Semaglutide for Diabetes

Trump Admin to Pause Medicaid Funding to Minnesota Because of Fraud Concerns

Maternity Services ‘Still Failing’ Women and Babies

Very Early ART Initiation in Children With HIV Could Lead to ART-Free Remission

When we interbred with Neanderthals, they were usually the fathers

Did Exercise Really Help Your Hip Osteoarthritis Patients?

Instagram Plans to Notify Parents if Teens ‘Repeatedly’ Search Suicide-Related Terms

Categories

Archives